This website only uses technically necessary cookies. No tracking, no analytics.
IBS
IBS#1622
$5.80-1.47%
IBS (IBS) is an actively traded crypto asset currently quoted at $28.11. With a market capitalization of $26,391,401, it sits at rank 621 by market value. Over the past 24 hours, trading volume reached $1,442,784 — visible activity, though clearly a smaller footprint than the major crypto names.
These numbers place IBS in a smaller, more price-sensitive corner of the market. A market cap in the tens of millions can shift quickly when buying or selling pressure changes, and any 24-hour volume figure is a short-term snapshot rather than a lasting trend. When comparing IBS with other coins, the metrics that matter most are whether volume holds steady, how the price reacts to broader market swings, and whether the ranking strengthens or fades over time. That combination is the backbone of any IBS report or IBS analysis July readers can rely on.
IBS may appeal to traders who follow lower-ranked assets with measurable daily turnover. The same profile calls for tighter risk control: sudden shifts in activity can affect entries and exits, and the quoted price can move quickly in a thinner market. Treat the live price, market cap, rank, and daily volume as the core signals in any IBS forecast or ongoing review.
This content was created with the assistance of generative AI. Learn more
What is IBS? A quick explainer
IBS is a crypto asset priced at $28.11, with a market cap of about $26.39 million and rank 621. Its 24-hour volume is about $1.44 million, so beginners should watch trading activity and price moves before trading.
Security check
Smart contract risk scan — checks for honeypots, hidden taxes and more.
This coin carries 3 risk flags. Not suitable for beginners. If you invest anyway: only money you can afford to lose entirely. No DCA plans, no leverage, no FOMO buys after a pump.
AI analysis
Clear bullish / neutral / bearish signal based on market data, on-chain security and macro signals.
Analysis from September 4, 2026
This analysis is refreshed automatically in the background.
Rating
Bearish78% confident
Confidence
Summary
IBS tells a rough story at the coin-specific level, even as the broader crypto market stays in an upbeat mood. The Fear & Greed Index sits at 74 — firmly in Greed territory — up from 68 just a week ago. That kind of momentum can fuel speculative buying, but it also hints at a market getting crowded with optimism, which tends to precede sharp corrections. For IBS itself, the concerns pile up: a security trust score of just 40, a mintable supply (meaning new tokens can be created at will), and a striking 96.38% of all holdings concentrated in the top ten addresses. On the plus side, the contract is open-source, shows no honeypot red flags, has attracted 203,238 holder addresses, and charges no tax on incoming transactions. That said, current price performance, developer activity, on-chain flows, social buzz, and token-unlock schedules are all unavailable — leaving little to counterbalance the concentration and contract-security concerns. This coin analysis suggests that while the wider market backdrop is friendly, IBS-specific transparency and security issues dominate the medium-term picture.
📰 Current News & Events
No current news is available for IBS. That means there's nothing linking recent market behavior to a specific project announcement, partnership, exchange listing, or other development. Regulatory news directly touching IBS is likewise unavailable at this time.
📈 Price Movement Analysis
You won't find a verified current price for IBS here, nor its 24-hour, 7-day, or 30-day changes — none of that data is available right now. The one hard reference point is the all-time high of 40.64, hit on May 17, 2026, but without a current price, there's no way to calculate how far the token sits from that peak. Zooming out, market-wide risk appetite has strengthened, with Fear & Greed climbing from 68 to 74 over the past week. Working against that tailwind, though, is a rising Dollar Index, which often dampens enthusiasm for riskier assets. With trading volume, market capitalization, news flow, and on-chain activity all missing from the picture, there's no solid basis for pinning down what's actually been driving IBS's price.
Strengths
✅The smart contract is open source, meaning anyone can inspect its code. It also shows no honeypot indication — the check performed didn't detect a mechanism designed to trap user funds.
✅The contract isn't a proxy contract, so its core logic isn't routed through a commonly used upgrade mechanism. That can cut down on one source of surprise changes, though other administrative controls remain undocumented.
✅IBS counts 203,238 holder addresses, pointing to fairly wide reach at the address level. That said, this doesn't cancel out concentration risk, since most of the actual supply still sits with a handful of large holders.
✅Incoming transactions carry zero contract tax, while outgoing ones are taxed at 2.5%. At least this part of the token's fee structure is clearly disclosed.
✅The broader market mood is supportive: Fear & Greed reads 74, and inflation has eased to 3.54% from 3.73%. Conditions like these tend to help demand for higher-risk crypto assets.
Risks
⚠️A security trust score of just 40 out of 100 signals real contract-related uncertainty. Security carries heavy weight in any coin forecast, since weaknesses here can directly threaten access to funds and undermine confidence in the token.
⚠️The top ten addresses hold 96.38% of the supply between them. That kind of concentration means a handful of large holders could move the market significantly with a single decision — and their identities and intentions remain unknown.
⚠️The contract is mintable, meaning new tokens can potentially be issued at any time. Without visibility into the maximum supply or supply ratio, there's no way to gauge how much future dilution could occur.
⚠️Developer activity, on-chain flows, and token-unlock schedules are all unavailable, making it impossible to confirm whether the project is actively maintained, whether large wallets are on the move, or whether fresh supply could hit the market.
⚠️Current price, trading volume, market capitalization, market rank, news coverage, and social data are missing across the board. These gaps make it genuinely hard to assess liquidity, fair valuation, recent momentum, or public interest in IBS.
📊 Macro context
The Fear & Greed Index reads 74 — labeled Greed — up from 68 over the last seven days. That reflects strong appetite for risk in the market, but it also raises the odds of a sentiment-driven pullback. The historical dataset isn't deep enough to produce a meaningful 90-day Fear & Greed comparison. On the monetary policy side, the Federal Funds Rate is holding steady at 3.63%, while annual inflation has cooled from 3.73% to 3.54% — a modestly friendlier liquidity backdrop overall. Working against that, the Dollar Index has climbed from 118.36 to 118.75, and a stronger dollar typically weighs on demand for riskier assets like IBS. No current regulatory developments specific to IBS are available.
❓ Frequently Asked Questions
Is IBS a good coin to watch right now?
This coin analysis finds some genuine positives — open-source code, no honeypot indication, and a large base of holder addresses. But a security score of 40, mintable supply, and 96.38% concentration among the top ten addresses tilt the overall picture toward strained rather than promising.
Why is IBS price moving the way it is?
It's hard to say with confidence — current price changes over 24 hours, 7 days, and 30 days aren't available for verification. Broader crypto sentiment is strong, with Fear & Greed at 74, but without IBS-specific news, volume, or on-chain data, there's no way to confirm what's actually driving the token.
What's the biggest risk investors are watching in this IBS coin forecast?
The standout strengths are the publicly viewable contract code, no honeypot indication, no proxy structure, and 203,238 holder addresses. The biggest risks are the weak security score, extreme ownership concentration, the ability to mint new tokens, and the lack of information on development activity, token unlocks, liquidity, and on-chain flows — all central concerns in this coin market analysis.
IBS is showing several red flags right now in exactly the areas that tend to matter most over a multi-week to multi-month horizon: security, ownership concentration, and developer activity. The contract trust score sits at a weak 40, and the ten largest addresses control a striking 95.53% of tracked tokens — a concentration level that leaves the market heavily dependent on a handful of holders. On the development side, the past four weeks show zero GitHub commits, zero merged code changes, and zero contributors, meaning there's no visible sign of ongoing technical work. Broader crypto sentiment, meanwhile, is running hot: the Fear & Greed Index reads 73 (Greed), up from 71 a week ago. That can fuel demand, but it also raises the odds of a sharp pullback if optimism cools. With current price action, on-chain flows, news, and token-unlock details all unavailable, the data we can actually verify paints a largely strained picture for IBS.
Aug 21, 2026, 12:05 AM
BearishBearish · 84% confident
IBS is showing a mostly troubling picture right now, dragged down by weak security markers and a near-total absence of development activity. The wider crypto market tells a different story: the Fear & Greed Index sits at 62 (Greed territory), having jumped 33 points from 29 — a notable swing back toward risk appetite. But that tailwind isn't enough to offset IBS's own red flags. Its trust score is just 40, the contract allows new tokens to be minted, and ownership is extremely concentrated: the 10 largest addresses hold 97.74% of the measured supply. Development looks dormant too, with zero commits, merged contributions, stars, or forks on record. Current price, recent returns, on-chain flows, and the token-unlock schedule are all unavailable, which leaves a lot of unanswered questions around valuation and where future supply pressure might come from.
